We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

47 hedge funds and large institutions have $121M invested in DermTech, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 4

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

114% more funds holding

Funds holding: 2247 (+25)

72% more capital invested

Capital invested by funds: $70M → $121M (+$50.7M)

Holders
47
Holders Change
+25
Holders Change %
+113.64%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
13
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
51
Wolverine Asset Management
Illinois
-$7K -656 Closed

DMTK Hedge Fund Activity: Q2 2020 in Review

47 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2020, worth a combined $121M — up 72% from $70M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DMTK positions and 4 closed out — a net gain of 25 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was Federated Hermes, adding an estimated $14.9M. The largest seller was Victory Capital Management, cutting an estimated $6.03M.

  • 47 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2020, up from 22 in Q1 2020.
  • Funds reported $121M of DermTech, Inc. Common Stock stock for Q2 2020, up 72% quarter-over-quarter.
  • 29 funds opened new DermTech, Inc. Common Stock positions in Q2 2020 and 4 closed out, a net change of +25 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q2 2020 was Federated Hermes, an estimated $14.9M added.
  • The largest DermTech, Inc. Common Stock seller in Q2 2020 was Victory Capital Management, an estimated $6.03M sold.

Based on aggregated 13F filings for Q2 2020.